Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myo-inositol vs Metformin in PCOS
NCT04892186Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Mar 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of myo-inositol in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Menstrual cycle at 6 months, Change in glucose metabolism at 6 months and 6 more. Started Mar 2021; status: completed.
02
Drugs
myo-inositol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04892186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04892186.